Treace Medical Concepts, Inc. (TMCI)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 585.92M |
| Enterprise value | 534.24M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 3.23 |
| Price/book (mrq) | 4.25 |
| Enterprise value/revenue | 3.06 |
| Enterprise value/EBITDA | -14.06 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.06 |
| 52-week change 3 | -60.07% |
| S&P500 52-week change 3 | 15.38% |
| 52-week high 3 | 27.97 |
| 52-week low 3 | 5.27 |
| 50-day moving average 3 | 9.87 |
| 200-day moving average 3 | 19.19 |
Share statistics
| Avg vol (3-month) 3 | 1.01M |
| Avg vol (10-day) 3 | 1.23M |
| Shares outstanding 5 | 61.68M |
| Implied shares outstanding 6 | 61.68M |
| Float 8 | 44.23M |
| % held by insiders 1 | 28.84% |
| % held by institutions 1 | 64.66% |
| Shares short (14 Nov 2023) 4 | 3.77M |
| Short ratio (14 Nov 2023) 4 | 3.13 |
| Short % of float (14 Nov 2023) 4 | 11.01% |
| Short % of shares outstanding (14 Nov 2023) 4 | 6.12% |
| Shares short (prior month 12 Oct 2023) 4 | 2.08M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 29 Sept 2023 |
Profitability
| Profit margin | -27.28% |
| Operating margin (ttm) | -43.72% |
Management effectiveness
| Return on assets (ttm) | -15.14% |
| Return on equity (ttm) | -47.64% |
Income statement
| Revenue (ttm) | 174.68M |
| Revenue per share (ttm) | 2.94 |
| Quarterly revenue growth (yoy) | 23.30% |
| Gross profit (ttm) | 114.31M |
| EBITDA | -43.79M |
| Net income avi to common (ttm) | -47.66M |
| Diluted EPS (ttm) | -0.78 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 122.16M |
| Total cash per share (mrq) | 1.98 |
| Total debt (mrq) | 70.49M |
| Total debt/equity (mrq) | 51.13% |
| Current ratio (mrq) | 5.64 |
| Book value per share (mrq) | 2.24 |
Cash flow statement
| Operating cash flow (ttm) | -40.47M |
| Levered free cash flow (ttm) | -41.96M |
© 2023 Yahoo. All rights reserved.